Tag
Healthcare Diagnostics
4 articles
Aspira Pathlab Q4 Net Loss ₹68.91 Lakh
Aspira Pathlab reported a standalone net loss of ₹68.91 lakh for Q4 March 2026 and ₹5.13 lakh for FY2026, with revenue of ₹652.24 lakh for the quarter.
The Board approved three key appointments: Neetu
Suraksha Diagnostic FY26 Revenue Up 22.5% YoY
Suraksha Diagnostic reported 22.5% YoY revenue growth to ₹3,135.78 million for FY26 with 15.8% EBITDA growth.
Q4 FY26 PAT declined 14.1% YoY to ₹61.59 million despite 24.7% revenue growth to ₹821.97 m
Suraksha Diagnostic FY26 Revenue Up 23% YoY
Suraksha Diagnostic reported FY26 consolidated revenue of ₹3,104.14 million, a 23% YoY increase, with EBITDA of ₹985.58 million.
The company added 20 centers since its December 2024 listing and comple
Modern Diagnostic Promoters Hold 72.85% Unencumbered
Modern Diagnostic promoters disclose 72.85% unencumbered shareholding for FY26 as per SEBI Takeover Regulations.
The disclosure confirms no pledges were created on 1.09 crore promoter-held shares duri